SI-BONE Inc (NASDAQ: SIBN) is a medical device company that designs and sells minimally invasive implants and instruments for surgical treatment of the sacropelvic anatomy. The company generates revenue through the sale of its implant systems to hospitals and surgical centers, where procedures are performed by trained surgeons. The filing excerpts provided do not contain sufficient detail to characterize segment revenue percentages, unit volumes, geographic mix, customer concentration, leadership tenure, founding year, or named competitors. Based solely on the available excerpts, a complete competitive positioning statement cannot be constructed. What is established by the filing is that SI-BONE is a public company listed on a U.S. exchange, files annual reports with the SEC, and qualifies as a well-known seasoned issuer as of the filing date of February 24, 2026, covering the fiscal year ended in that reporting period.

Revenue model

The filing excerpts do not provide sufficient detail to describe the revenue model with specificity.

Products and services

The filing excerpts do not enumerate specific products or product lines with sufficient detail to describe them accurately.

Customers and end markets

The filing excerpts do not identify specific customers, customer types, or end markets with sufficient detail.

Value-chain role

The filing excerpts do not provide sufficient detail to characterize SI-BONE's value-chain role.

Geographic exposure

The filing excerpts do not specify geographic revenue mix or operational footprint.

Source: SEC 10-K, filed 2026-02-24

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories AngioDynamics Inc Artivion Inc Senseonics Holdings Inc AxoGen Inc Cardiovascular Systems Inc Outset Medical Inc Inogen Inc Mesa Laboratories Inc ViewRay, Inc.